Patent · US Active

Liquid tasimelteon formulations and methods of use thereof

US11202770B2 · kind B2 · utility

0Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2020
Grant dateDec 21, 2021
Priority date—
Expiry dateDec 11, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Liquid suspensions of tasimelteon and methods for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.